NCT06060197View on ClinicalTrials.gov

MCT8 Deficiency Caregiver Study

CompletedOBSERVATIONAL

Enrollment

21

Participants

Timeline

Start Date

August 23, 2022

Primary Completion Date

April 12, 2024

Study Completion Date

April 12, 2024

Conditions

Monocarboxylate Transporter 8 (MCT8) DeficiencyAllan-Herndon-Dudley Syndrome

Trial Locations (1)

OX4 4GA

Vitaccess Ltd, Oxford

All Listed Sponsors

collaborator

Vitaccess Ltd

INDUSTRY

lead

Rare Thyroid Therapeutics International AB

INDUSTRY